Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.
METHODS
A patient with residual craniopharyngioma experienced a rapid tumor relapse during growth hormone therapy.


OBJECTIVE
We present this case and remind physicians that it is necessary to reevaluate the safety of growth hormone therapy in patients with residual craniopharyngioma.
Niu
Dau-Ming
DM
Department of Pediatrics, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan.
Guo
Wan-Yuo
WY
Pan
Hung-Chi
HC
Wong
Tai-Tong
TT
D001827:Body Height / Q000187:drug effects; D002648:Child; D003397:Craniopharyngioma / Q000175:diagnosis* / Q000601:surgery; D006130:Growth Disorders / Q000517:prevention & control; D013006:Growth Hormone / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000601:surgery; D018365:Neoplasm, Residual / Q000601:surgery; D010911:Pituitary Neoplasms / Q000175:diagnosis* / Q000601:surgery; D016634:Radiosurgery; D013997:Time Factors
D013006:Growth Hormone